Celgene Corp (CELG) 91.36 $CELG
Final Glance: Biotechnology companies
AP - Tue Aug 19, 5:09PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
Midday Glance: Biotechnology companies
AP - Tue Aug 19, 3:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Aug 19, 12:20PM CDT
Plegridy's less frequent dosing schedule could help it gain share from other beta interferon treatments.
Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate
Business Wire - Tue Aug 19, 6:30AM CDT
Celgene Corporation (NASDAQ:CELG) today announced that results of a study evaluating the combination of REVLIMID(R) (lenalidomide) with rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone (R-CHOP) in untreated diffuse large b-cell lymphoma (DLBCL) were published online ahead of print in the Journal of Clinical Oncology.
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins
at Investor's Business Daily - Mon Aug 18, 12:46PM CDT
Some of the fattest annual profit margins come from drugmakers whose products are meant to make people healthier. Today's Screen of the Day is Healthy Profit Margin and includes four highly rated drug stocks. Don't miss out on Jazz Pharmaceuticals...
3 Reasons Celgene Corporation's Stock Could Rise
Sean Williams, The Motley Fool - Motley Fool - Mon Aug 18, 11:58AM CDT
It's been an incredible three years for Celgene , as evidenced by its better-than-tripling in share price and noticeable top-line and bottom-line growth. CELG data by YCharts We saw this growth carry over into its recently reported...
Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and More
at The Street - Mon Aug 18, 11:40AM CDT
TheStreet's Jim Cramer answers Twitter (TWTR) questions on Walmart (WMT), Yelp (YELP), Kinder Morgan Energy Partners (KMP), WhiteWave (WWAV) and more.
Early Glance: Biotechnology companies
AP - Mon Aug 18, 9:29AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Uptrend Call Working As Celgene Stock Rises 20.6% (CELG)
Comtex SmarTrend(R) - Fri Aug 15, 11:04AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $73.94. In approximately 4 months, Celgene has returned 20.62% as of today's recent price of $89.18.
Celgene (CELG) Approaches New Upside Target of $90.29
Comtex SmarTrend(R) - Fri Aug 15, 9:00AM CDT
Shares of Celgene (NASDAQ:CELG) have bullishly opened above the pivot of $88.74 today and have reached the first resistance level of $89.38. Analysts will be watching for a cross of the next upside pivot targets of $90.29 and $91.84.
Stock Market News for August 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 9:10AM CDT
Benchmarks ended in the green as gains in biotech stocks offset discouraging retail sales numbers
After Yesterday's Rally of 2.27% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Aug 13, 3:53PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $86.56 to a high of $88.76. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $87.51 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Trade-Ideas: Celgene (CELG) Is Today's Momo Momentum Stock
at The Street - Wed Aug 13, 10:45AM CDT
Trade-Ideas LLC identified Celgene (CELG) as a momo momentum candidate
Final Glance: Biotechnology companies
AP - Tue Aug 19, 5:09PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
Midday Glance: Biotechnology companies
AP - Tue Aug 19, 3:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Aug 19, 12:20PM CDT
Plegridy's less frequent dosing schedule could help it gain share from other beta interferon treatments.
Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate
Business Wire - Tue Aug 19, 6:30AM CDT
Celgene Corporation (NASDAQ:CELG) today announced that results of a study evaluating the combination of REVLIMID(R) (lenalidomide) with rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone (R-CHOP) in untreated diffuse large b-cell lymphoma (DLBCL) were published online ahead of print in the Journal of Clinical Oncology.
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins
at Investor's Business Daily - Mon Aug 18, 12:46PM CDT
Some of the fattest annual profit margins come from drugmakers whose products are meant to make people healthier. Today's Screen of the Day is Healthy Profit Margin and includes four highly rated drug stocks. Don't miss out on Jazz Pharmaceuticals...
3 Reasons Celgene Corporation's Stock Could Rise
Sean Williams, The Motley Fool - Motley Fool - Mon Aug 18, 11:58AM CDT
It's been an incredible three years for Celgene , as evidenced by its better-than-tripling in share price and noticeable top-line and bottom-line growth. CELG data by YCharts We saw this growth carry over into its recently reported...
Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and More
at The Street - Mon Aug 18, 11:40AM CDT
TheStreet's Jim Cramer answers Twitter (TWTR) questions on Walmart (WMT), Yelp (YELP), Kinder Morgan Energy Partners (KMP), WhiteWave (WWAV) and more.
Early Glance: Biotechnology companies
AP - Mon Aug 18, 9:29AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Uptrend Call Working As Celgene Stock Rises 20.6% (CELG)
Comtex SmarTrend(R) - Fri Aug 15, 11:04AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $73.94. In approximately 4 months, Celgene has returned 20.62% as of today's recent price of $89.18.
Celgene (CELG) Approaches New Upside Target of $90.29
Comtex SmarTrend(R) - Fri Aug 15, 9:00AM CDT
Shares of Celgene (NASDAQ:CELG) have bullishly opened above the pivot of $88.74 today and have reached the first resistance level of $89.38. Analysts will be watching for a cross of the next upside pivot targets of $90.29 and $91.84.
Stock Market News for August 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 9:10AM CDT
Benchmarks ended in the green as gains in biotech stocks offset discouraging retail sales numbers
After Yesterday's Rally of 2.27% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Aug 13, 3:53PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $86.56 to a high of $88.76. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $87.51 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Trade-Ideas: Celgene (CELG) Is Today's Momo Momentum Stock
at The Street - Wed Aug 13, 10:45AM CDT
Trade-Ideas LLC identified Celgene (CELG) as a momo momentum candidate
